Opdivo, Twitter, 8/9/2019 1:07:55 AM, 206152


FAQ | Problem?

Opdivo_2019-08-08_15-10-11.xlsx
Opdivo_2019-08-08_15-10-11.xlsx
From:
NodeXLExcelAutomator
Uploaded on:
August 09, 2019
Short Description:
Opdivo via NodeXL http://bit.ly/2MPS9oK
@bmsnews
@galeno1999
@tusaludhispana
@efrainalvaradoa
@mvas52
@dompabloa
@quimiov
@fundacionbadan
@gambiste1
@satoruo

Top hashtags:
#opdivo
#nivolumab
#zoladex
#avastin
#rituximab
#pharma
#nexavar
#melanoma
#caracas
#sutent

Description:
Description
The graph represents a network of 1,733 Twitter users whose tweets in the requested range contained "Opdivo", or who were replied to or mentioned in those tweets. The network was obtained from the NodeXL Graph Server on Thursday, 08 August 2019 at 22:11 UTC.

The requested start date was Thursday, 08 August 2019 at 00:01 UTC and the maximum number of tweets (going backward in time) was 5,000.

The tweets in the network were tweeted over the 98-day, 18-hour, 10-minute period from Wednesday, 01 May 2019 at 00:44 UTC to Wednesday, 07 August 2019 at 18:54 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

The graph is directed.

The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.

The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.


Author Description


Overall Graph Metrics
Vertices : 1733
Unique Edges : 1844
Edges With Duplicates : 1175
Total Edges : 3019
Number of Edge Types : 3
Tweet : 899
Mentions : 1873
Replies to : 247
Self-Loops : 899
Reciprocated Vertex Pair Ratio : 0.0140158439975625
Reciprocated Edge Ratio : 0.0276442307692308
Connected Components : 445
Single-Vertex Connected Components : 330
Maximum Vertices in a Connected Component : 602
Maximum Edges in a Connected Component : 1535
Maximum Geodesic Distance (Diameter) : 18
Average Geodesic Distance : 6.450347
Graph Density : 0.000554379128691918
Modularity : 0.574688
NodeXL Version : 1.0.1.418

Top Influencers: Top 10 Vertices, Ranked by Betweenness Centrality
Top URLs
Top URLs in Tweet in Entire Graph:
[66] https://www.buzzfeed.com/jp/satoruosuka/cancer-opdivo?utm_source=dynamic&utm_campaign=bfsharetwitter
[28] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol
[13] https://www.fiercepharma.com/pharma/merck-s-keytruda-passing-opdivo-bags-double-head-and-neck-cancer-ok
[12] https://www.reuters.com/article/us-bristol-myers-cancer/bristol-myers-opdivo-fails-late-stage-brain-cancer-trial-idUSKCN1SF1B8?feedType=RSS&feedName=healthNews
[10] https://endpts.com/bristol-myers-does-it-again-disappointing-investors-with-another-failed-opdivo-phiii-as-227-flops/
[10] http://brazilsfecompany.blogspot.com.br/2018/04/2018-Top-20-Medicamentos-Mais-Vendidos-no-Mundo.html
[10] https://twitter.com/BrazilSFE
[10] http://benzaiten.dyndns.org/roller/ugya/entry/honjo-tasuku-opdivo
[9] https://medcitynews.com/2019/05/bmss-immunotherapy-drug-opdivo-fails-in-phase-iii-brain-cancer-study/
[8] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol?linkId=69441570

Top URLs in Tweet in G1:
[12] https://www.reuters.com/article/us-bristol-myers-cancer/bristol-myers-opdivo-fails-late-stage-brain-cancer-trial-idUSKCN1SF1B8?feedType=RSS&feedName=healthNews
[10] http://brazilsfecompany.blogspot.com.br/2018/04/2018-Top-20-Medicamentos-Mais-Vendidos-no-Mundo.html
[10] https://twitter.com/BrazilSFE
[6] https://www.fiercepharma.com/pharma/merck-s-keytruda-passing-opdivo-bags-double-head-and-neck-cancer-ok
[6] https://lungcancersymptomsx.com/a-hope-for-mesothelioma-patients-with-new-lung-cancer-drug-opdivo.html
[5] https://www.reuters.com/article/us-bristol-myers-cancer/bristol-myers-opdivo-fails-late-stage-brain-cancer-trial-idUSKCN1SF1B8?feedType=RSS&feedName=healthNews&utm_source=dlvr.it&utm_medium=twitter
[5] https://medcitynews.com/2019/05/bmss-immunotherapy-drug-opdivo-fails-in-phase-iii-brain-cancer-study/
[5] https://www.buzzfeed.com/jp/satoruosuka/cancer-opdivo?utm_source=dynamic&utm_campaign=bfsharetwitter
[4] https://www.reuters.com/article/us-bristol-myers-cancer/bristol-myers-opdivo-fails-late-stage-brain-cancer-trial-idUSKCN1SF1B8
[4] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol

Top URLs in Tweet in G2:
[61] https://www.buzzfeed.com/jp/satoruosuka/cancer-opdivo?utm_source=dynamic&utm_campaign=bfsharetwitter
[2] https://www.buzzfeed.com/jp/satoruosuka/cancer-opdivo

Top URLs in Tweet in G3:
[8] https://endpts.com/bristol-myers-does-it-again-disappointing-investors-with-another-failed-opdivo-phiii-as-227-flops/
[3] https://endpts.com/bristol-myers-star-opdivo-fails-survival-test-in-a-matchup-with-nexavar-aimed-at-shaking-up-the-big-hcc-market/
[3] https://www.fiercebiotech.com/biotech/complete-response-rate-nektar-melanoma-trial-hits-34
[2] https://seekingalpha.com/news/3473157
[2] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol
[2] https://twitter.com/bio_clouseau/status/1143111436241162241
[2] https://www.youtube.com/watch?v=WDDxSO_7DxU

[1] https://investorplace.com/2019/08/bristol-myers-squibb-bmy-stock-opdivo-otezla/
[1] http://clincancerres.aacrjournals.org/content/early/2019/06/25/1078-0432.CCR-18-3944
[1] http://ir.exelixis.com/news-releases/news-release-details/exelixis-initiating-phase-3-pivotal-trial-cosmic-313

Top URLs in Tweet in G5:
[4] https://news.bms.com/press-release/asco19/bristol-myers-squibb-announces-first-presentation-results-opdivo-nivolumab-plus?linkId=68472488
[3] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol?linkId=69441570
[3] https://pharmaphorum.com/views-and-analysis/rd-roundup-novartis-crispr-opdivo/
[3] https://finance.yahoo.com/news/bristol-myers-bmy-presents-multiple-130301742.html
[2] https://media.bayer.com/baynews/baynews.nsf/id/Bayer-Bristol-Myers-Squibb-Ono-Pharmaceutical-enter-a-clinical-collaboration-agreement-investigate
[2] https://ir.ziopharm.com/news-releases/news-release-details/ziopharm-oncology-completes-enrollment-controlled-il-12-plus
[2] https://pharmaphorum.com/news/bms-has-another-opdivo-setback-after-liver-cancer-trial-failure/?utm_source=pharmaphorum+Daily+Newsletter&utm_campaign=e64cb98ac2-EMAIL_CAMPAIGN_2019_06_25_11_55&utm_medium=email&utm_term=0_a54496134b-e64cb98ac2-438901029
[1] https://twitter.com/MVAS52/status/1128343252564881410
[1] https://www.curetoday.com/articles/presurgical-opdivo-may-benefit-patients-with-glioblastoma
[1] https://ir.nektar.com/news-releases/news-release-details/nektar-therapeutics-and-bristol-myers-squibb-announce-us-fda

Top URLs in Tweet in G6:
[1] https://twitter.com/dw_turkce/status/1068794562246787072

Top URLs in Tweet in G7:
[1] https://www.instagram.com/p/Bzw9zainZet5RPei55oe3q-Oms2GkPxZ0fBmCQ0/?igshid=kgblw7wy62dl

Top URLs in Tweet in G8:
[15] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol
[4] https://news.bms.com/press-release/bmy/bristol-myers-squibb-announces-results-checkmate-459-study-evaluating-opdivo-nivol?linkId=69441570
[3] https://bit.ly/2x70MSX
[1] https://twitter.com/InfoCancerFoie/status/1143217317888823296
[1] https://clinicaltrials.gov/ct2/show/NCT02576509?term=nivolumab+checkmate&cond=Hepatocellular+Carcinoma&rank=3

Top URLs in Tweet in G9:
[5] https://www.fiercepharma.com/pharma/merck-s-keytruda-passing-opdivo-bags-double-head-and-neck-cancer-ok
[3] http://www.pharmatimes.com/news/fda_grants_opdivo_combo_breakthrough_designation_for_melanoma_1296184
[2] http://www.pharmatimes.com/news/imfinzi,_opdivo_among_latest_smc_decisions_1290505
[2] http://firstwordpharma.com/node/1654976?tsid=28®ion_id=6
[2] https://www.fiercepharma.com/pharma/bristol-myers-squibb-bayer-team-up-opdivo-stivarga-combo-colorectal-cancer
[1] http://www.pharmatimes.com/news/bms_opdivo_disappoints_in_late-stage_trial_1292613
[1] http://www.pharmatimes.com/news/bayer,_bms,_ono_team_up_to_investigate_stivarga,_opdivo_combo_1294892
[1] https://twitter.com/Wattwurm73/status/1134423298199236608
[1] https://www.edisongroup.com/publication/mammalian-movement/24028/
[1] https://www.firstwordpharma.com/node/1655044

Top URLs in Tweet in G10:
[3] http://braintumorstorageoptions.ca
[1] http://Braintumorstorageoptions.ca
[1] https://www.curetoday.com/articles/genomic-features-may-aid-immunotherapys-role-in-glioblastoma
[1] https://www.curetoday.com/articles/opdivo-plus-radiation-fails-to-prolong-survival-in-subtype-of-glioblastoma
[1] https://www.curetoday.com/articles/yervoy-plus-opdivo-appears-to-be-a-cost-effective-treatment-option-in-kidney-cancer
[1] https://www.curetoday.com/articles/immunotherapy-combo-improves-responses-in-patients-with-metastatic-bladder-cancer

Top Domains
Top Domains in Tweet in Entire Graph:
[71] buzzfeed.com
[54] fiercepharma.com
[51] twitter.com
[50] bms.com
[38] dlvr.it
[32] reuters.com
[24] pharmatimes.com
[22] endpts.com
[22] medcitynews.com
[21] co.jp

Top Domains in Tweet in G1:
[29] reuters.com
[26] fiercepharma.com
[22] dlvr.it
[20] twitter.com
[15] medcitynews.com
[14] blogspot.com
[13] jiho.jp
[12] co.jp
[12] pharmatimes.com
[11] einnews.com

Top Domains in Tweet in G2:
[63] buzzfeed.com

Top Domains in Tweet in G3:
[12] endpts.com
[9] twitter.com
[7] bms.com
[6] dlvr.it
[4] fiercebiotech.com
[3] seekingalpha.com
[2] evaluate.com
[2] yahoo.com
[2] youtube.com
[2] businesswire.com

Top Domains in Tweet in G5:
[9] bms.com
[9] pharmaphorum.com
[4] twitter.com
[4] thepharmaletter.com
[4] pharmaceutical-technology.com
[3] pharmashots.com
[3] yahoo.com
[2] consalud.es
[2] acobur.es
[2] bayer.com

Top Domains in Tweet in G6:
[1] twitter.com

Top Domains in Tweet in G7:
[1] instagram.com

Top Domains in Tweet in G8:
[19] bms.com
[3] bit.ly
[1] twitter.com
[1] clinicaltrials.gov

Top Domains in Tweet in G9:
[10] fiercepharma.com
[8] pharmatimes.com
[5] firstwordpharma.com
[1] twitter.com
[1] edisongroup.com
[1] centerforbiosimilars.com

Top Domains in Tweet in G10:
[4] braintumorstorageoptions.ca
[4] curetoday.com

Top Hashtags
Top Hashtags in Tweet in Entire Graph:
[214] opdivo
[144] nivolumab
[64] zoladex
[48] avastin
[48] rituximab
[40] pharma
[39] nexavar
[38] melanoma
[36] caracas
[27] sutent



Top Hashtags in Tweet in G1:
[50] opdivo
[20] pharma
[16] nivolumab
[12] cancer
[12] januvia
[12] lantus
[12] prevnar13
[12] neulasta
[10] janumet
[10] prevener

Top Hashtags in Tweet in G3:
[11] asco19
[8] nivolumab
[5] melanoma
[5] opdivo
[3] carcinome
[2] pharma
[2] sorafenib
[2] hcc
[2] keytruda
[1] dcvax

Top Hashtags in Tweet in G4:
[89] opdivo
[79] nivolumab
[64] zoladex
[48] rituximab
[38] nexavar
[36] caracas
[34] avastin
[25] revlimib
[25] capecitabina
[24] docetaxel

Top Hashtags in Tweet in G5:
[12] melanoma
[10] opdivo
[6] media
[6] hcc
[5] pharma
[4] immunotherapy
[4] mesothelioma
[4] mesotelioma
[4] asbestos
[4] amianto

Top Hashtags in Tweet in G7:
[15] valencia
[15] venezuela
[15] quimioterapias
[15] opdivo
[15] nivolumab

Top Hashtags in Tweet in G8:
[8] hcc
[5] hepatocellularcarcinoma
[5] livercancer
[5] treatment
[3] pressrelease
[2] nivolumab
[2] sorafenib
[1] media

Top Hashtags in Tweet in G9:
[5] pharmanews
[4] news
[3] lifesciences
[3] pharma
[2] xbrane
[2] nivolumab
[2] opdivo
[1] biosimilar
[1] biosimilarnews
[1] biosimilars

Top Hashtags in Tweet in G10:
[1] kidneycancer

Top Words
Top Words in Tweet in Entire Graph:
[1062] Words in Sentiment List#1: Positive
[1178] Words in Sentiment List#2: Negative
[4] Words in Sentiment List#3: Angry/Violent
[44583] Non-categorized Words
[46823] Total Words
[1558] opdivo
[463] nivolumab
[449] cancer
[426] bristol
[329] myers

Top Words in Tweet in G1:
[463] opdivo
[214] cancer
[206] bristol
[140] myers
[97] trial
[97] nivolumab
[92] fails
[87] phase
[83] squibb
[80] study

Top Words in Tweet in G2:
[247] satoruo
[187] がんと免疫については
[187] 以前にバズフィードに解説記事を書いています
[187] 免疫はたしかにがん治療に重要なのですが
[187] それを一般生活にある食品
[187] 食事療法などで
[187] 大きく変えて
[187] がん細胞を殺せるような変化を起こすことは困難であることがわかっています
[187] 記事をご参考に
[66] ã

Top Words in Tweet in G3:
[300] opdivo
[202] bmy
[117] keytruda
[69] 2
[67] checkmate
[62] 1l
[58] nsclc
[57] non
[55] andybiotech
[52] cancer

Top Words in Tweet in G4:
[102] opdivo
[89] #opdivo
[89] disponible
[82] nivolumab
[80] fundacionbadan
[79] #nivolumab
[70] mg
[66] medicamento
[64] #zoladex
[64] 10

Top Words in Tweet in G5:
[103] opdivo
[48] bmsnews
[37] trial
[33] nivolumab
[32] data
[26] combo
[23] cancer
[23] phase
[22] 1
[21] ziop

Top Words in Tweet in G6:
[63] bin
[63] bir
[62] opdivo
[61] barisyarkadas
[61] 2
[60] kutusu
[60] 28
[60] tl'den
[60] satılan
[60] ve

Top Words in Tweet in G7:
[72] ampollas
[59] opdivo
[47] nivolumab
[44] requiere
[44] urgencia
[29] 18
[16] danibolanos
[16] 12
[16] 100mg
[16] 6

Top Words in Tweet in G8:
[51] sorafenib
[50] nivolumab
[35] survival
[33] improve
[26] trial
[25] results
[25] checkmate
[25] 459
[24] overall
[20] show

Top Words in Tweet in G9:
[87] opdivo
[71] pd
[68] made
[60] bristol
[59] myers
[58] thenci
[57] nivolumab
[45] squibb
[45] 1
[39] keytruda

Top Words in Tweet in G10:
[27] opdivo
[25] keytruda
[19] patients
[16] dcvax
[15] label
[13] vaccine
[10] mesenchymal
[10] pd1
[10] 5
[8] group

Top Word Pairs
Top Word Pairs in Tweet in Entire Graph:
[326] bristol,myers
[193] opdivo,nivolumab
[187] がんと免疫については,以前にバズフィードに解説記事を書いています
[187] 以前にバズフィードに解説記事を書いています,免疫はたしかにがん治療に重要なのですが
[187] 免疫はたしかにがん治療に重要なのですが,それを一般生活にある食品
[187] それを一般生活にある食品,食事療法などで
[187] 食事療法などで,大きく変えて
[187] 大きく変えて,がん細胞を殺せるような変化を起こすことは困難であることがわかっています
[187] がん細胞を殺せるような変化を起こすことは困難であることがわかっています,記事をご参考に
[186] satoruo,がんと免疫については

Top Word Pairs in Tweet in G1:
[139] bristol,myers
[81] opdivo,fails
[73] brain,cancer
[72] myers,squibb
[67] opdivo,nivolumab
[57] late,stage
[53] cancer,trial
[52] bristol,myers'
[52] stage,brain
[50] lung,cancer

Top Word Pairs in Tweet in G2:
[187] がんと免疫については,以前にバズフィードに解説記事を書いています
[187] 以前にバズフィードに解説記事を書いています,免疫はたしかにがん治療に重要なのですが
[187] 免疫はたしかにがん治療に重要なのですが,それを一般生活にある食品
[187] それを一般生活にある食品,食事療法などで
[187] 食事療法などで,大きく変えて
[187] 大きく変えて,がん細胞を殺せるような変化を起こすことは困難であることがわかっています
[187] がん細胞を殺せるような変化を起こすことは困難であることがわかっています,記事をご参考に
[186] satoruo,がんと免疫については
[61] https,t
[61] t,co

Top Word Pairs in Tweet in G3:
[50] keytruda,1l
[50] 1l,non
[50] non,squamous
[49] final,nail
[49] nail,coffin
[49] coffin,opdivo
[49] opdivo,indeed
[49] indeed,inferior
[49] inferior,keytruda
[49] squamous,nsclc

Top Word Pairs in Tweet in G4:
[64] nivolumab,10
[64] 10,mg
[64] mg,ml
[64] ml,4ml
[64] 4ml,opdivo
[61] #opdivo,#nivolumab
[61] sucursal,cortijos
[61] cortijos,nivolumab
[61] opdivo,sol
[61] sol,iny

Top Word Pairs in Tweet in G5:
[20] opdivo,nivolumab
[17] bristol,myers
[14] il,12
[13] controlled,il
[12] nivolumab,opdivo
[11] combination,trial
[10] myers,squibb
[10] phase,1
[10] 1,combination
[10] 12,plus

Top Word Pairs in Tweet in G6:
[60] 2,kutusu
[60] kutusu,28
[60] 28,bin
[60] bin,tl'den
[60] tl'den,satılan
[60] satılan,ve
[60] ve,ay
[60] ay,kullanılmak
[60] kullanılmak,zorunda
[60] zorunda,opdivo

Top Word Pairs in Tweet in G7:
[47] opdivo,nivolumab
[44] requiere,urgencia
[40] ampollas,opdivo
[29] urgencia,18
[29] 18,ampollas
[16] nivolumab,12
[16] 12,ampollas
[16] ampollas,100mg
[16] 100mg,6
[16] 6,ampollas

Top Word Pairs in Tweet in G8:
[25] checkmate,459
[22] overall,survival
[20] results,checkmate
[20] 459,trial
[20] trial,show
[20] show,nivolumab
[20] nivolumab,improve
[20] improve,overall
[20] survival,compared
[20] compared,sorafenib

Top Word Pairs in Tweet in G9:
[59] bristol,myers
[52] nivolumab,opdivo
[45] myers,squibb
[44] pd,1
[31] made,bristol
[31] pembrolizumab,keytruda
[28] 1,blocking
[25] opdivo,made
[24] made,merck
[23] pd,l1

Top Word Pairs in Tweet in G10:
[25] keytruda,opdivo
[11] label,keytruda
[7] gene,expression
[6] still,alive
[6] mesenchymal,gene
[5] low,pd1
[5] dcvax,label
[5] 9,patients
[5] patients,still
[5] alive,5

Top Replied-To
Top Replied-To in Entire Graph:
@thenci
@fundacionbadan
@bmsnews
@buscandomedicin
@freddyflash1
@bradloncar
@julioespinoza4
@drfahrettinkoca
@medcancervzla
@veteranshealth

Top Replied-To in G3:
@andybiotech
@matthewherper
@bradloncar
@adamfeuerstein
@rogerb06385286
@bertrandbio
@notthatkindofdr
@biotechobserver
@maverickny
@adar170

Top Replied-To in G4:
@fundacionbadan
@buscandomedicin
@freddyflash1
@medcancervzla
@julioespinoza4
@quimiov
@serviciopublive
@ca601ff0a58d454
@sebuscasedona
@fncancer

Top Replied-To in G5:
@bmsnews
@thomasubarton1
@dodawuk
@biotech2050
@bradloncar
@mvas52
@curemelanoma

Top Replied-To in G6:
@barisyarkadas

Top Replied-To in G7:
@bmsnews
@santicancerosa
@medicinatogogm1

Top Replied-To in G9:
@thenci
@veteranshealth
@ncicancertrials
@catrionam_d

Top Replied-To in G10:
@claredotexe
@shelnic6
@brainsurgn1989
@mineurosurgery
@melhoop10
@cure_magazine
@katelovesthe80s
@paul_bayne
@txsunflowersoul
@amhoov

Top Mentioned
Top Mentioned in Entire Graph:
@satoruo
@fundacionbadan
@barisyarkadas
@andybiotech
@bmsnews
@serviciopublive
@esedesalud
@donamed_ve
@ayudasosvzla
@sebuscasedona

Top Mentioned in G1:
@clinicalphase
@cmencke
@judsontelemed
@melanoma_bio
@ray_noble1
@womens_womens
@nailethv
@lmmarknaden
@larvol

Top Mentioned in G2:
@satoruo

Top Mentioned in G3:
@andybiotech
@bradloncar
@johncendpts
@adamfeuerstein
@biostocks
@jacobplieth
@semodough
@matthewherper
@endpts
@sxbegle

Top Mentioned in G4:
@fundacionbadan
@serviciopublive
@esedesalud
@donamed_ve
@ayudasosvzla
@buscandomedicin
@sebuscasedona
@medcancervzla
@sosmedicina
@medicinasve

Top Mentioned in G5:
@bmsnews
@ziopharm
@curemelanoma
@biotech2050
@bayerpharma
@bayer
@nektarnews
@bermesproject
@linda_
@tarisbio

Top Mentioned in G6:
@barisyarkadas
@pelinunker
@dw_turkce
@nserdarturhal

Top Mentioned in G7:
@danibolanos
@fundacionbadan
@face_uc
@fapuv
@apucoficial
@marybolanos
@galeno1999
@efrainalvaradoa
@galeagustavo

Top Mentioned in G8:
@bclc_group
@augustonyc
@aeehliver
@infocancerfoie
@bmsnews
@dufour_jf
@jturnesv
@adiazgonzalezmd

Top Mentioned in G9:
@fwpharma
@fiercepharma
@pharmatimes
@xbranebiopharma
@nci_cssi
@treda10
@thenci
@bradloncar
@edisonhealth
@digitalpharma

Top Mentioned in G10:
@doughboyspod
@mbmbam
@thezonecast
@edwardlemon3
@gordquotes
@dglaucomflecken
@mcsassymd

Top Tweeters
Top Tweeters in Entire Graph:
@yuuji_k1
@myalliesnews
@medicinehelp
@follementbijoux
@allstocknews
@rocketnews1
@politicalhedge
@mharvey816
@tradnews_
@razzletazzlemag

Top Tweeters in G1:
@myalliesnews
@medicinehelp
@follementbijoux
@allstocknews
@rocketnews1
@politicalhedge
@razzletazzlemag
@marketcurrents
@gogiuk
@newsfromspi

Top Tweeters in G2:
@teaparty0000
@fuku_chihuahua
@hayohater
@suigadou
@kumikokatase
@mariajinha
@kinginsunago
@kgn_works
@hiroo
@socio34050

Top Tweeters in G3:
@mharvey816
@bioportfolio
@mr_showkz99
@rogerl04
@gambiste1
@cancer_bio
@donnayoungdc
@johnnosta
@jimcramer
@blossomvinson

Top Tweeters in G4:
@duinconsueloc
@vetehugo
@elpitazotv
@pura_miel
@arquitecty
@yolimaarellano
@pecescd
@hapariciog1108
@mayvenezolana
@serviciopublive

Top Tweeters in G5:
@linda_adao
@urotoday
@isanidad
@hernangraffe
@samadovaabditch
@pharmaphorum
@swoodruff
@ecsalud_com
@ibasecretariat
@biotech2050

Top Tweeters in G6:
@dw_turkce
@barisyarkadas
@no_rumuz
@ezgisutoprak
@nathan61641442
@sebahatturkmen
@kkbirocuk1
@fkoruyucu1
@svmaktryldz
@zehrabozca

Top Tweeters in G7:
@cristobalvega
@mairaazuje
@antoniojdo
@glanzs
@reinaseq
@anyrmontes28
@amigoflorespad
@efrainalvaradoa
@nrodriguez7
@vanesadepombo

Top Tweeters in G8:
@drjhk
@fpazgomez
@tamarnegie
@hakosemi
@carmenvcello
@sepdigestiva
@rplanasv
@jturnesv
@drjaviercrespo
@birminghamliver

Top Tweeters in G9:
@saintporres
@treda10
@annemarievtw
@fwpharma
@veteranshealth
@fiercepharma
@thenci
@vanprobindia
@pharmatimes
@plexusventures

Top Tweeters in G10:
@mcsassymd
@edwardlemon3
@cure_magazine
@dglaucomflecken
@gordquotes
@shelnic6
@melhoop10
@katelovesthe80s
@johnny70250027
@npnowgaug


We use necessary cookies to make our site work. We’d like to set additional cookies to understand site usage, make site improvements and to remember your settings. We also use cookies set by other sites to help deliver content from their services.